サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1267039

世界の細胞・遺伝子治療用ドラッグデリバリーデバイス市場：考察と予測 (2029年まで)

Global Cell and Gene Therapy Drug Delivery Devices Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の細胞・遺伝子治療用ドラッグデリバリーデバイス市場：考察と予測 (2029年まで)
出版日: 2023年05月01日
発行: QYResearch
ページ情報: 英文 113 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、細胞・遺伝子治療用ドラッグデリバリーデバイス (Cell and Gene Therapy Drug Delivery Devices) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Sterile Insulin Syringe
    • Pre-Filled Syringe
    • Infusion Bags
  • 市場：用途別
    • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Luxturna
    • Kymriah
    • Provenge
    • Zolgensma
    • Yescarta
    • Strimvelis
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場展望 (2018-2029)
  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場成長トレンド：地域別
    • 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：地域別: 2018 VS 2022 VS 2029
    • 細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模実績：地域別 (2018-2023)
    • 細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模予測：地域別 (2024-2029)
  • 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場動向
    • 細胞・遺伝子治療用ドラッグデリバリーデバイス 業界動向
    • 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場の促進要因
    • 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場の課題
    • 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 細胞・遺伝子治療用ドラッグデリバリーデバイス ：競合別
    • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの収益：企業別 (2018-2023)
    • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの収益シェア：企業別 (2018-2023)
  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 細胞・遺伝子治療用ドラッグデリバリーデバイス, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場集中度
    • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 細胞・遺伝子治療用ドラッグデリバリーデバイスの収益 2022
  • 世界の主要企業 細胞・遺伝子治療用ドラッグデリバリーデバイス 本社 および提供地域
  • 世界の主要企業 細胞・遺伝子治療用ドラッグデリバリーデバイス, 製品およびアプリケーション
  • 世界の主要企業 細胞・遺伝子治療用ドラッグデリバリーデバイス, 業界参入時期
  • M&A, 拡張計画

第4章 細胞・遺伝子治療用ドラッグデリバリーデバイス 内訳データ：タイプ別

  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模実績：タイプ別 (2018-2023)
  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模予測：タイプ別 (2024-2029)

第5章 細胞・遺伝子治療用ドラッグデリバリーデバイス 内訳データ：用途別

  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模実績：用途別 (2018-2023)
  • 世界の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模 (2018-2029)
  • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2018-2023)
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2024-2029)
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：タイプ別 (2018-2029)
  • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2018-2023)
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2024-2029)
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：用途別 (2018-2029)
  • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別 (2018-2023)
    • 北米の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模 (2018-2029)
  • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2018-2023)
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2024-2029)
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：タイプ別 (2018-2029)
  • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2018-2023)
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2024-2029)
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：用途別 (2018-2029)
  • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別 (2018-2023)
    • 欧州の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模 (2018-2029)
  • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別
    • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2018-2023)
    • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2024-2029)
    • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：タイプ別 (2018-2029)
  • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別
    • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2018-2023)
    • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2024-2029)
    • 中国の細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模 (2018-2029)
  • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2018-2023)
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2024-2029)
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：タイプ別 (2018-2029)
  • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2018-2023)
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2024-2029)
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：用途別 (2018-2029)
  • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：地域別
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：地域別 (2018-2023)
    • アジア地域 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイスの市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 細胞・遺伝子治療用ドラッグデリバリーデバイス 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Amgen, Inc.
  • Bausch and Lomb Incorporated
  • Becton, Dickinson and Company
  • Bluebird bio, Inc.
  • Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
  • Dendreon Pharmaceuticals LLC.
  • Helixmith Co., Ltd (ViroMed Co., Ltd)
  • Human Stem Cell Institute
  • Kite Pharma, Inc.
  • Kolon Tissue Gene, inc.
  • Novartis AG
  • Orchard Therapeutics plc.
  • Pfizer, Inc.
  • Renova Therapeutics
  • Spark Therapeutics, Inc.
  • uniQure N.V.
  • Vericel Corporation

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Sterile Insulin Syringe
  • Table 3. Key Players of Pre-Filled Syringe
  • Table 4. Key Players of Infusion Bags
  • Table 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2018-2023)
  • Table 9. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2024-2029)
  • Table 11. Cell and Gene Therapy Drug Delivery Devices Market Trends
  • Table 12. Cell and Gene Therapy Drug Delivery Devices Market Drivers
  • Table 13. Cell and Gene Therapy Drug Delivery Devices Market Challenges
  • Table 14. Cell and Gene Therapy Drug Delivery Devices Market Restraints
  • Table 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players (2018-2023)
  • Table 17. Global Top Cell and Gene Therapy Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2022)
  • Table 18. Global Cell and Gene Therapy Drug Delivery Devices Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Headquarters and Area Served
  • Table 21. Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Product and Application
  • Table 22. Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2018-2023)
  • Table 26. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2024-2029)
  • Table 28. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application (2018-2023)
  • Table 30. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application (2024-2029)
  • Table 32. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America Cell and Gene Therapy Drug Delivery Devices Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe Cell and Gene Therapy Drug Delivery Devices Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia Cell and Gene Therapy Drug Delivery Devices Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. Amgen, Inc. Company Details
  • Table 65. Amgen, Inc. Business Overview
  • Table 66. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 67. Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 68. Amgen, Inc. Recent Developments
  • Table 69. Bausch and Lomb Incorporated Company Details
  • Table 70. Bausch and Lomb Incorporated Business Overview
  • Table 71. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product
  • Table 72. Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 73. Bausch and Lomb Incorporated Recent Developments
  • Table 74. Becton, Dickinson and Company Company Details
  • Table 75. Becton, Dickinson and Company Business Overview
  • Table 76. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product
  • Table 77. Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 78. Becton, Dickinson and Company Recent Developments
  • Table 79. Bluebird bio, Inc. Company Details
  • Table 80. Bluebird bio, Inc. Business Overview
  • Table 81. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 82. Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 83. Bluebird bio, Inc. Recent Developments
  • Table 84. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
  • Table 85. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
  • Table 86. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product
  • Table 87. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 88. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
  • Table 89. Dendreon Pharmaceuticals LLC. Company Details
  • Table 90. Dendreon Pharmaceuticals LLC. Business Overview
  • Table 91. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 92. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 93. Dendreon Pharmaceuticals LLC. Recent Developments
  • Table 94. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
  • Table 95. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
  • Table 96. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product
  • Table 97. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 98. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
  • Table 99. Human Stem Cell Institute Company Details
  • Table 100. Human Stem Cell Institute Business Overview
  • Table 101. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product
  • Table 102. Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 103. Human Stem Cell Institute Recent Developments
  • Table 104. Kite Pharma, Inc. Company Details
  • Table 105. Kite Pharma, Inc. Business Overview
  • Table 106. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 107. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 108. Kite Pharma, Inc. Recent Developments
  • Table 109. Kolon Tissue Gene, inc. Company Details
  • Table 110. Kolon Tissue Gene, inc. Business Overview
  • Table 111. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 112. Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 113. Kolon Tissue Gene, inc. Recent Developments
  • Table 114. Novartis AG Company Details
  • Table 115. Novartis AG Business Overview
  • Table 116. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product
  • Table 117. Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 118. Novartis AG Recent Developments
  • Table 119. Orchard Therapeutics plc. Company Details
  • Table 120. Orchard Therapeutics plc. Business Overview
  • Table 121. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 122. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 123. Orchard Therapeutics plc. Recent Developments
  • Table 124. Pfizer, Inc. Company Details
  • Table 125. Pfizer, Inc. Business Overview
  • Table 126. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 127. Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 128. Pfizer, Inc. Recent Developments
  • Table 129. Renova Therapeutics Company Details
  • Table 130. Renova Therapeutics Business Overview
  • Table 131. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product
  • Table 132. Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 133. Renova Therapeutics Recent Developments
  • Table 134. Spark Therapeutics, Inc. Company Details
  • Table 135. Spark Therapeutics, Inc. Business Overview
  • Table 136. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 137. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 138. Spark Therapeutics, Inc. Recent Developments
  • Table 139. uniQure N.V. Company Details
  • Table 140. uniQure N.V. Business Overview
  • Table 141. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product
  • Table 142. uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 143. uniQure N.V. Recent Developments
  • Table 144. Vericel Corporation Company Details
  • Table 145. Vericel Corporation Business Overview
  • Table 146. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product
  • Table 147. Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023) & (US$ Million)
  • Table 148. Vericel Corporation Recent Developments
  • Table 149. Research Programs/Design for This Report
  • Table 150. Key Data Information from Secondary Sources
  • Table 151. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type: 2022 VS 2029
  • Figure 3. Sterile Insulin Syringe Features
  • Figure 4. Pre-Filled Syringe Features
  • Figure 5. Infusion Bags Features
  • Figure 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2022 VS 2029
  • Figure 8. Luxturna Case Studies
  • Figure 9. Kymriah Case Studies
  • Figure 10. Provenge Case Studies
  • Figure 11. Zolgensma Case Studies
  • Figure 12. Yescarta Case Studies
  • Figure 13. Strimvelis Case Studies
  • Figure 14. Cell and Gene Therapy Drug Delivery Devices Report Years Considered
  • Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 17. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region: 2022 VS 2029
  • Figure 18. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players in 2022
  • Figure 19. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2022)
  • Figure 20. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2022
  • Figure 21. North America Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • Figure 23. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • Figure 24. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2018-2029)
  • Figure 25. United States Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Canada Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. Europe Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2018-2029) & (US$ Million)
  • Figure 28. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • Figure 29. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • Figure 30. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2018-2029)
  • Figure 31. Germany Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. France Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. U.K. Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Italy Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Russia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 37. China Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2018-2029) & (US$ Million)
  • Figure 38. China Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • Figure 39. China Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • Figure 40. Asia Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2018-2029) & (US$ Million)
  • Figure 41. Asia Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • Figure 42. Asia Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • Figure 43. Asia Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2018-2029)
  • Figure 44. Japan Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. South Korea Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. China Taiwan Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. India Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. Australia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 50. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size YoY (2018-2029) & (US$ Million)
  • Figure 51. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • Figure 52. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • Figure 53. Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2018-2029)
  • Figure 54. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. Israel Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 59. GCC Countries Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 60. Amgen, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 61. Bausch and Lomb Incorporated Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 62. Becton, Dickinson and Company Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 63. Bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 64. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 65. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 66. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 67. Human Stem Cell Institute Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 68. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 69. Kolon Tissue Gene, inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 70. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 71. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 72. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 73. Renova Therapeutics Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 74. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 75. uniQure N.V. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 76. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
  • Figure 77. Bottom-up and Top-down Approaches for This Report
  • Figure 78. Data Triangulation
  • Figure 79. Key Executives Interviewed
目次

This research report focuses on the Cell and Gene Therapy Drug Delivery Devices Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Sterile Insulin Syringe
    • 1.2.3 Pre-Filled Syringe
    • 1.2.4 Infusion Bags
  • 1.3 Market by Application
    • 1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Luxturna
    • 1.3.3 Kymriah
    • 1.3.4 Provenge
    • 1.3.5 Zolgensma
    • 1.3.6 Yescarta
    • 1.3.7 Strimvelis
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2018-2029)
  • 2.2 Global Cell and Gene Therapy Drug Delivery Devices Growth Trends by Region
    • 2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Region (2018-2023)
    • 2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2024-2029)
  • 2.3 Cell and Gene Therapy Drug Delivery Devices Market Dynamics
    • 2.3.1 Cell and Gene Therapy Drug Delivery Devices Industry Trends
    • 2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers
    • 2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges
    • 2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Cell and Gene Therapy Drug Delivery Devices by Players
    • 3.1.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2018-2023)
    • 3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2018-2023)
  • 3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio
    • 3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2022
  • 3.5 Global Key Players of Cell and Gene Therapy Drug Delivery Devices Head office and Area Served
  • 3.6 Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Product and Application
  • 3.7 Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type

  • 4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2018-2023)
  • 4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2024-2029)

5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application

  • 5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2018-2023)
  • 5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
  • 6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023)
    • 6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029)
    • 6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • 6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023)
    • 6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029)
    • 6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • 6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
    • 6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2018-2023)
    • 6.4.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
  • 7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023)
    • 7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029)
    • 7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • 7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023)
    • 7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029)
    • 7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • 7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
    • 7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2018-2023)
    • 7.4.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
  • 8.2 China Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 8.2.1 China Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023)
    • 8.2.2 China Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029)
    • 8.2.3 China Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • 8.3 China Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 8.3.1 China Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023)
    • 8.3.2 China Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029)
    • 8.3.3 China Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
  • 9.2 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 9.2.1 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023)
    • 9.2.2 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029)
    • 9.2.3 Asia Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • 9.3 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 9.3.1 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023)
    • 9.3.2 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029)
    • 9.3.3 Asia Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • 9.4 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Region
    • 9.4.1 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2018-2023)
    • 9.4.3 Asia Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Amgen, Inc.
    • 11.1.1 Amgen, Inc. Company Details
    • 11.1.2 Amgen, Inc. Business Overview
    • 11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.1.5 Amgen, Inc. Recent Developments
  • 11.2 Bausch and Lomb Incorporated
    • 11.2.1 Bausch and Lomb Incorporated Company Details
    • 11.2.2 Bausch and Lomb Incorporated Business Overview
    • 11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.2.5 Bausch and Lomb Incorporated Recent Developments
  • 11.3 Becton, Dickinson and Company
    • 11.3.1 Becton, Dickinson and Company Company Details
    • 11.3.2 Becton, Dickinson and Company Business Overview
    • 11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.3.5 Becton, Dickinson and Company Recent Developments
  • 11.4 Bluebird bio, Inc.
    • 11.4.1 Bluebird bio, Inc. Company Details
    • 11.4.2 Bluebird bio, Inc. Business Overview
    • 11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.4.5 Bluebird bio, Inc. Recent Developments
  • 11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
    • 11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
    • 11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
    • 11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
  • 11.6 Dendreon Pharmaceuticals LLC.
    • 11.6.1 Dendreon Pharmaceuticals LLC. Company Details
    • 11.6.2 Dendreon Pharmaceuticals LLC. Business Overview
    • 11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.6.5 Dendreon Pharmaceuticals LLC. Recent Developments
  • 11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
    • 11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
    • 11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
    • 11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
  • 11.8 Human Stem Cell Institute
    • 11.8.1 Human Stem Cell Institute Company Details
    • 11.8.2 Human Stem Cell Institute Business Overview
    • 11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.8.5 Human Stem Cell Institute Recent Developments
  • 11.9 Kite Pharma, Inc.
    • 11.9.1 Kite Pharma, Inc. Company Details
    • 11.9.2 Kite Pharma, Inc. Business Overview
    • 11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.9.5 Kite Pharma, Inc. Recent Developments
  • 11.10 Kolon Tissue Gene, inc.
    • 11.10.1 Kolon Tissue Gene, inc. Company Details
    • 11.10.2 Kolon Tissue Gene, inc. Business Overview
    • 11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.10.5 Kolon Tissue Gene, inc. Recent Developments
  • 11.11 Novartis AG
    • 11.11.1 Novartis AG Company Details
    • 11.11.2 Novartis AG Business Overview
    • 11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.11.5 Novartis AG Recent Developments
  • 11.12 Orchard Therapeutics plc.
    • 11.12.1 Orchard Therapeutics plc. Company Details
    • 11.12.2 Orchard Therapeutics plc. Business Overview
    • 11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.12.5 Orchard Therapeutics plc. Recent Developments
  • 11.13 Pfizer, Inc.
    • 11.13.1 Pfizer, Inc. Company Details
    • 11.13.2 Pfizer, Inc. Business Overview
    • 11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.13.5 Pfizer, Inc. Recent Developments
  • 11.14 Renova Therapeutics
    • 11.14.1 Renova Therapeutics Company Details
    • 11.14.2 Renova Therapeutics Business Overview
    • 11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.14.5 Renova Therapeutics Recent Developments
  • 11.15 Spark Therapeutics, Inc.
    • 11.15.1 Spark Therapeutics, Inc. Company Details
    • 11.15.2 Spark Therapeutics, Inc. Business Overview
    • 11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.15.5 Spark Therapeutics, Inc. Recent Developments
  • 11.16 uniQure N.V.
    • 11.16.1 uniQure N.V. Company Details
    • 11.16.2 uniQure N.V. Business Overview
    • 11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.16.5 uniQure N.V. Recent Developments
  • 11.17 Vericel Corporation
    • 11.17.1 Vericel Corporation Company Details
    • 11.17.2 Vericel Corporation Business Overview
    • 11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction
    • 11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2018-2023)
    • 11.17.5 Vericel Corporation Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details